STIM

Neuronetics, Inc. Common Stock

2.38

USD

+0.12

+5.31%

Oct 29, 15:59 UTC -4

Closed

Pre-Market

2.37

-0.01

-0.55%

Neuronetics, Inc. Common Stock (STIM) Earnings

STIM Earnings Reports

Positive Surprise Ratio

STIM beat 20 of 33 last estimates.

61%

Next Report

Next Week

Date of Next Report

Nov 04, 2026

Estimate for Q3 26 (Revenue/ EPS)

$41.23M

-$0.08

Implied change from Q2 26 (Revenue/ EPS)

-0.80%

+100.00%

Implied change from Q3 25 (Revenue/ EPS)

+10.55%

-38.46%

Neuronetics, Inc. Common Stock earnings per share and revenue

On Aug 11, 2026, STIM reported earnings of -0.04 USD per share (EPS) for Q2 26, beating the estimate of -0.12 USD, resulting in a 68.00% surprise. Revenue reached 41.57 million, compared to an expected 40.98 million, with a 1.44% difference. The market reacted with a +47.00% price change (close before vs. close after earnings).

Looking ahead to Q3 26, -- analysts forecast an EPS of -0.08 USD, with revenue projected to reach 41.23 million USD, implying an increase of 100.00% EPS, and decrease of -0.80% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Alphatec Holdings, Inc.

Report Date

Oct 29, 2026 For Q3 26

Estimate

$0.09

Actual

$0.09

Surprise

-6.83%

Beta Bionics, Inc. Common Stock

Report Date

Oct 27, 2026 For Q3 26

Estimate

-$0.53

Actual

-$0.52

Surprise

+2.73%

Integra LifeSciences Holdings

Report Date

Oct 21, 2026 For Q3 26

Estimate

$0.57

Actual

$0.59

Surprise

+3.04%

OrthoPediatrics Corp. Common Stock

Report Date

Oct 27, 2026 For Q3 26

Estimate

-$0.21

Actual

-$0.23

Surprise

-4.88%

ClearPoint Neuro, Inc. Common Stock

Report Date

Oct 28, 2026 For Q3 26

Estimate

-$0.32

Actual

-$0.24

Surprise

+25.30%

Thermo Fisher Scientific, Inc.

Report Date

Oct 21, 2026 For Q3 26

Estimate

$6.46

Actual

$6.68

Surprise

+3.29%

Intuitive Surgical Inc.

Report Date

Oct 20, 2026 For Q3 26

Estimate

$2.69

Actual

$3.00

Surprise

+11.29%

IQVIA Holdings Inc.

Report Date

Oct 27, 2026 For Q3 26

Estimate

$3.30

Actual

$3.34

Surprise

+0.97%

Glaukos Corporation

Report Date

Oct 28, 2026 For Q3 26

Estimate

-$0.09

Actual

$0.47

Surprise

+611.98%

Axogen, Inc. Common Stock

Report Date

Oct 28, 2026 For Q3 26

Estimate

$0.14

Actual

$0.21

Surprise

+47.06%

FAQ

What were Neuronetics, Inc. Common Stock's earnings and revenue for the latest quarter Q2 2026?

For Q2 2026, Neuronetics, Inc. Common Stock reported EPS of -$0.04, beating estimates by 68%, and revenue of $41.57M, 1.44% above expectations.

How did the market react to Neuronetics, Inc. Common Stock's Q2 2026 earnings?

The stock price moved up 47%, changed from $2.17 before the earnings release to $3.19 the day after.

When is Neuronetics, Inc. Common Stock expected to report next?

The next earning report is scheduled for Nov 04, 2026.

What are the forecasts for Neuronetics, Inc. Common Stock's next earnings report?

Based on -- analysts, Neuronetics, Inc. Common Stock is expected to report EPS of -$0.08 and revenue of $41.23M for Q3 2026.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.